IJMPCERO  Vol.3 No.4 , November 2014
Does Change in the Effect of Source Strength of the High Dose Rate 192Iridium Radio-Isotope on Local Control and Late Normal Tissue Toxicity (Bladder and Rectum) in the Treatment of Carcinoma Cervix
ABSTRACT
Aim: To analyse and assess the effect of dose rate of 192ir-source strength on late complications and local control rate during treatment of carcinoma cervix. Materials and Methods: One hundred and two cases of carcinoma cervix were included in the study. All patients were treated with a curative intent with radical dose of radiation as per the department protocol. All patients were treated with both EBRT plus Brachytherapy with Inj. Cisplatin 40 mg/m2 weekly. Patients were divided into 2 groups based on activity i.e. group A (10-6Ci) and group B (5-2Ci). After brachytherapy, point doses were analysed based on ICRU 38 recommendations. During follow up, morbidities were evaluated using RTOG grading system. Results: There was no difference in local control and distant metastasis in both groups after six months of follow up. Late Complications were comparable in both groups irrespective of source strength. Bladder complications were minimal with no significant difference in both study groups. Further Patients were divided into four groups i.e. BED of ICRU rectal point (<100 Gy3 and ≥100 Gy3) and source strength (10-6Ci and 5-2Ci), when BED was >100 Gy3 resulted in higher late rectal complication rate (P < 0.05) compared to BED < 100 Gy3. Conclusion: This study suggests that change in source activity did not make a difference in local control, late rectal and bladder morbidities at 6 months of follow up. Longer follow up is required to assess long term results and morbidities.

Cite this paper
Sudhakar, K. , Gunaseelan, K. , Reddy, K. , Saravanan, K. and Vinin, N. (2014) Does Change in the Effect of Source Strength of the High Dose Rate 192Iridium Radio-Isotope on Local Control and Late Normal Tissue Toxicity (Bladder and Rectum) in the Treatment of Carcinoma Cervix. International Journal of Medical Physics, Clinical Engineering and Radiation Oncology, 3, 210-217. doi: 10.4236/ijmpcero.2014.34027.
References
[1]   ICMR Report on Incidence and Epidemiology of Cancer in India 2001-2004.

[2]   Eifel, P.J. (2000) Chemoradiation for Carcinoma of the Cervix: Advances and Opportunities. Radiation Research, 154, 229-236.
http://dx.doi.org/10.1667/0033-7587(2000)154[0229:CFCOTC]2.0.CO;2

[3]   Haie-Meder, C., de Crevoisier, R., Bruna, A., Lhomme, C., Pautier, P., Morice, P., et al. (2005) Concomitant Chemoradiation in Patients with Cervix Cancer. Bulletin du Cancer, 92, 1032-854.

[4]   Manning, M.A., Zwicker, R.D., Arthur, D.W. and Arnfield, M. (2005) Biologic Treatment Planning for High-Dose-Rate Brachytherapy. International Journal of Radiation Oncology*Biology*Physics, 49, 839-845.
http://dx.doi.org/10.1016/S0360-3016(00)01453-X

[5]   Brooks, S, Bowens, P, Lowe, G, Brayant, L and Hoskin, P.J. (2005) Cervical Brachytherapy Utilizing Ring Applicator: Comparison of Standard and Conformal Loading. International Journal of Radiation Oncology*Biology*Physics, 63, 934-939.
http://dx.doi.org/10.1016/j.ijrobp.2005.07.963

[6]   Chen, S.W, Wang, C.J., Leung, S.W., et al. (1998) The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: Evidence suggestive of consequential late effect (CQLE). International Journal of Radiation Oncology*Biology*Physics, 40, 758-64.

[7]   Das, D., Chaudhuri, S., Deb, A.R., Gangopadhay, S. and Ray, A. (2011) Treatment of Cervical Carcinoma with High Dose Rate Intracavitary Brachytherapy: Two Years Follow Up Study. Asian Pacific Journal of Cancer Prevention, 12, 807-810.

[8]   Grigsby, P.W. and Perez, C.A. (1991) Radiotherapy Alone for Medically Inoperable Carcinoma of the Cervix: Stage IA and Carcinoma in Situ. International Journal of Radiation Oncology*Biology*Physics, 21, 375-378.
http://dx.doi.org/10.1016/0360-3016(91)90785-3

[9]   Suzuki, O., Yoshioka, Y., Isohashi, F., et al. (2008) Effect of High Dose Rate Ir-192 Source Activity on Late Rectal Bleeding after Intracavitary Radiation Therapy for Uterine Cervix Cancer. International Journal of Radiation Oncology*Biology*Physics, 71, 1329-1334.
http://dx.doi.org/10.1016/j.ijrobp.2007.11.074

[10]   Ishohashi, F., Yoshioka, Y., Koizumi, M., et al. (2010) Rectal Dose Source Strength of the High Dose Rate Iridium-192 Both Affect Late Rectal Bleeding after intracavitary Radiation Therapy For Uterine Cervical Carcinoma. International Journal of Radiation Oncology*Biology*Physics, 77, 758-764.
http://dx.doi.org/10.1016/j.ijrobp.2009.05.030

[11]   Ogino, I., Kitamura, T., Okamoto, N., et al. (1995) Late Rectal Complication Following High Dose Rate Intracavitary Brachytherapy in Cancer of the Cervix. International Journal of Radiation Oncology*Biology*Physics, 31, 725-734.
http://dx.doi.org/10.1016/0360-3016(94)00547-8

[12]   Toita, T. (2009) Current Status and Perspectives of Brachytherapy for Cervical Cancer. International Journal of Clinical Oncology, 14, 25-30.

[13]   Ferrigno, R., Dos, P.E., Pellizzon, A.C., et al. (2001) High-Dose-Rate Brachytherapy in the Treatment of Uterine Cervix Cancer. Analysis of Dose Effectiveness and Late Complications. International Journal of Radiation Oncology*Biology*Physics, 50, 1123-1135.
http://dx.doi.org/10.1016/S0360-3016(01)01533-4

[14]   Chen, W.S., et al. (2003) High Dose Rate Brachytherapy for Elderly Patients with Uterine Cervical Cancer. Japanese Journal of Clinical Oncology, 33, 221-228.
http://dx.doi.org/10.1093/jjco/hyg041

[15]   Nakono, T., Kato, S., Ohno, T., et al. (2005) Long Term Results of High-Dose Rate Intracavitary Brachytherapy for Squamous Cell Carcinoma of the Uterine Cervix. Cancer, 103, 92-102.
http://dx.doi.org/10.1002/cncr.20734

[16]   Montana, G.S., Fowler, W.C., Varia, M.A., Walton, L.A., Mack, Y. and Shemanski, L. (1986) Carcinoma of the Cervix, Stage III. Results of Radiation Therapy. Cancer, 57, 148-154.
http://dx.doi.org/10.1002/1097-0142(19860101)57:1<148::AID-CNCR2820570130>3.0.CO;2-7

 
 
Top